Page last updated: 2024-10-18

dalteparin and Dengue

dalteparin has been researched along with Dengue in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Dengue: An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.

Research Excerpts

ExcerptRelevanceReference
" She also developed right proximal femoral deep vein thrombosis, and was commenced on subcutaneous enoxaparin and warfarin."3.88Dengue shock syndrome complicated with acute liver failure and kidney injury, infective endocarditis, and deep vein thrombosis: a case report. ( Munasinghe, J; Samarasekara, K, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Samarasekara, K1
Munasinghe, J1

Other Studies

1 other study available for dalteparin and Dengue

ArticleYear
Dengue shock syndrome complicated with acute liver failure and kidney injury, infective endocarditis, and deep vein thrombosis: a case report.
    Journal of medical case reports, 2018, Oct-30, Volume: 12, Issue:1

    Topics: Acute Kidney Injury; Adult; Anticoagulants; Coinfection; Dengue; Endocarditis, Bacterial; Enoxaparin

2018